{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:12:17Z","timestamp":1767665537851,"version":"3.48.0"},"reference-count":107,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T00:00:00Z","timestamp":1454803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Tumori"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Combined modality therapy is a mainstay option for thoracic malignancies and head and neck cancers. The integration of different strategies is based on the multidisciplinary approach of modern clinical oncology. Radiation oncologists have to be educated, trained, and updated to provide state-of-the-art care to cancer patients and thus educational meetings are crucial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The Italian Association of Radiation Oncology Young Members Working Group (AIRO Giovani) organized its 8\n                      <jats:sup>th<\/jats:sup>\n                      national meeting, focused on combination therapy in lung, esophageal, and head and neck cancer (with a specific focus on larynx-preservation strategies for larynx\/hypopharynx tumors), involving young professionals working in Italy. The meeting was addressed to young radiation oncologists, presenting state-of-the-art knowledge, based on the latest evidence in this field. We performed a review of the current literature based on the highlights of the Congress.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The multimodality approach of head and neck and thoracic malignancies includes surgery, chemotherapy, and radiotherapy, but also has to take into account new information and data coming from basic and translational research and including molecular biology, genetics, and immunology. All these aspects are crucial for the treatment of non-small-cell lung cancer and esophageal, esophagogastric junction, and larynx\/hypopharynx malignancies. The integration of different treatments in the clinical decision-making process to combine therapies is crucial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combination therapy has proved to be a consolidated approach in these specific oncologic settings, highlighting the importance of multimodality management in modern clinical oncology. Dedicated meetings on specific topics are helpful to improve knowledge and skills of young professionals in radiation oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5301\/tj.5000525","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T05:25:02Z","timestamp":1470979502000},"page":"459-471","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Combined Modality Therapy for Thoracic and head and Neck Cancers: A Review of Updated Literature Based on a Consensus Meeting"],"prefix":"10.1177","volume":"102","author":[{"given":"Pierfrancesco","family":"Franco","sequence":"first","affiliation":[{"name":"Department of Oncology, Radiation Oncology, University of Turin, Turin - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Ospedale Sacro Cuore-Don Calabria, Negrar (Verona) - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Dionisi","sequence":"additional","affiliation":[{"name":"Department of Oncology, Proton Therapy Unit, Azienda Provinciale per i Servizi Sanitari (APSS), Trento - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Fiore","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, Campus Bio-Medico University, Rome - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Chiesa","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department-Gemelli ART, Sacred Heart Catholic University, Rome - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Vagge","sequence":"additional","affiliation":[{"name":"Department of Radio-Oncology, IRCCS AOU San Martino IST, National Institute for Cancer Research, Genoa - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cellini","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department-Gemelli ART, Sacred Heart Catholic University, Rome - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Caravatta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Regional Oncological Hospital, Cagliari - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Tombolini","sequence":"additional","affiliation":[{"name":"Department of Sensory Organs, Institute of Otorhinolaryngology, Audiology and Phoniatrics, Sapienza University, Rome - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorenza","family":"De Rose","sequence":"additional","affiliation":[{"name":"Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center, Rozzano (Milan) - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Icro","family":"Meattini","sequence":"additional","affiliation":[{"name":"Department of Sperimental and Clinical Biomedical Sciences, Radiation Oncology, AOU Careggi, Florence - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Mortellaro","sequence":"additional","affiliation":[{"name":"Radiation Oncology Department, ARNAS Civico Hospital, Palermo - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Apicella","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, University Hospital \u2018Maggiore della Carit\u00e0,\u2019 Novara - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Marino","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, Centro REM, Catania - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Greto","sequence":"additional","affiliation":[{"name":"Department of Sperimental and Clinical Biomedical Sciences, Radiation Oncology, AOU Careggi, Florence - Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,2,7]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2012.07.011"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0729-y"},{"issue":"2","key":"e_1_3_2_4_2","first-page":"177","article-title":"AIRO (Italian Association of Radiation Oncology) and the AIRO Palliative Care Group","volume":"97","author":"De Bari B","year":"2011","unstructured":"De BariB ChiesaS FilippiAR ; AIRO (Italian Association of Radiation Oncology) and the AIRO Palliative Care Group. The INTER-ROMA project\u2014a survey among Italian radiation oncologists on their approach to the treatment of bone metastases. Tumori 2011;97 (2)177\u2013184","journal-title":"The INTER-ROMA project\u2014a survey among Italian radiation oncologists on their approach to the treatment of bone metastases. Tumori"},{"issue":"4","key":"e_1_3_2_5_2","first-page":"660","article-title":"AIRO Young and AIRO Prostate cancer Working Group","volume":"118","author":"Alongi F","year":"2013","unstructured":"AlongiF De BariB FrancoP ; AIRO Young and AIRO Prostate cancer Working Group. The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer. Radiol Med (Torino) 2013;118 (4)660\u2013678","journal-title":"The PROCAINA (PROstate CAncer INdication Attitudes) Project (Part I): a survey among Italian radiation oncologists on postoperative radiotherapy in prostate cancer. Radiol Med (Torino)"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-013-0925-z"},{"issue":"8","key":"e_1_3_2_7_2","first-page":"522","article-title":"AIRO Giovani (Italian Association of Radiation Oncology-Young Members Working Group)","volume":"31","author":"Ciammella P","year":"2013","unstructured":"CiammellaP De BariB FiorentinoA ; AIRO Giovani (Italian Association of Radiation Oncology-Young Members Working Group). The \u201cBUONGIORNO\u201d project: burnout syndrome among young Italian radiation oncologists. Cancer Invest 2013;31 (8)522\u2013528","journal-title":"The \u201cBUONGIORNO\u201d project: burnout syndrome among young Italian radiation oncologists. Cancer Invest"},{"issue":"6","key":"e_1_3_2_8_2","first-page":"e236","article-title":"AIRO Giovani Italian Association of Radiation Oncology-Young Members Working Group","volume":"100","author":"De Bari B","year":"2014","unstructured":"De BariB FrancoP CiammellaP ; AIRO Giovani Italian Association of Radiation Oncology-Young Members Working Group. The PEDRO (Pocketable Electronic Devices in Radiation Oncology) project: how clinical practice is changing among young radiation oncologists. Tumori 2014;100 (6)e236\u2013e242","journal-title":"The PEDRO (Pocketable Electronic Devices in Radiation Oncology) project: how clinical practice is changing among young radiation oncologists. Tumori"},{"issue":"2","key":"e_1_3_2_9_2","first-page":"365","article-title":"AIRO Giovani (Italian Association of Radiation Oncology-Young Members Working Group), of yDEGRO (Young German Society of Radiation Oncology), of SYROG (Spanish Young Radiation Oncology Group), of SEOR (Spanish Society of Radiation Oncology), of SPRO (Portuguese Society of Radiotherapy and Oncology-Young Members Working Group), SPRO Jovem), and of FYO (The Danish Association of Young Oncologists)","volume":"15","author":"De Bari B","year":"2016","unstructured":"De BariB FrancoP NiyaziM ; AIRO Giovani (Italian Association of Radiation Oncology-Young Members Working Group), of yDEGRO (Young German Society of Radiation Oncology), of SYROG (Spanish Young Radiation Oncology Group), of SEOR (Spanish Society of Radiation Oncology), of SPRO (Portuguese Society of Radiotherapy and Oncology-Young Members Working Group), SPRO Jovem), and of FYO (The Danish Association of Young Oncologists). The Pocketable Electronic Devices in radiation Oncology (PEDRO) Project: how the use of tools in medical decision making is changing? Technol Cancer Res Treat 2016;15 (2)365\u2013376","journal-title":"The Pocketable Electronic Devices in radiation Oncology (PEDRO) Project: how the use of tools in medical decision making is changing? Technol Cancer Res Treat"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089161309900601"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1700\/1778.19280"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2360"},{"issue":"8","key":"e_1_3_2_13_2","first-page":"1573","article-title":"Panel Members","volume":"26","author":"Eberhardt WE","year":"2015","unstructured":"EberhardtWE De RuysscherD WederW ; Panel Members. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol 2015;26 (8)1573\u20131588","journal-title":"2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol"},{"issue":"4","key":"e_1_3_2_14_2","first-page":"225","article-title":"Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines","volume":"3","author":"De Leyn P","year":"2014","unstructured":"De LeynP DoomsC KuzdzalJ Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines. Transl Lung Cancer Res 2014;3 (4)225\u2013233","journal-title":"Transl Lung Cancer Res"},{"issue":"9722","key":"e_1_3_2_15_2","first-page":"1267","article-title":"NSCLC Meta-analyses Collaborative Group","volume":"375","author":"Arriagada R","year":"2010","unstructured":"ArriagadaR AuperinA BurdettS ; NSCLC Meta-analyses Collaborative Group. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010;375 (9722)1267\u20131277","journal-title":"Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet"},{"issue":"9124","key":"e_1_3_2_16_2","first-page":"257","article-title":"PORT Meta-analysis Trialists Group","volume":"352","year":"1998","unstructured":"PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998;352 (9124)257\u2013263","journal-title":"Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.5380"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.09.033"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.04.003"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.11.052"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60737-6"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.12.066"},{"issue":"7","key":"e_1_3_2_23_2","first-page":"636","article-title":"German Lung Cancer Cooperative Group","volume":"9","author":"Thomas M","year":"2008","unstructured":"ThomasM R\u00fcbeC HoffknechtP ; German Lung Cancer Cooperative Group. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 2008;9 (7)636\u2013648","journal-title":"Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.10.003"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26689"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.03.015"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.2543"},{"issue":"1","key":"e_1_3_2_28_2","first-page":"114","article-title":"EORTC LCG and RT Group","volume":"43","author":"Belderbos J","year":"2007","unstructured":"BelderbosJ UitterhoeveL van ZandwijkN ; EORTC LCG and RT Group. Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). Eur J Cancer 2007;43 (1)114\u2013121","journal-title":"Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973). Eur J Cancer"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2360"},{"issue":"3","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdj117","article-title":"Meta-Analysis of Cisplatin\/carboplatin based Concomitant Chemotherapy in non-small cell Lung Cancer (MAC3-LC) Group. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients","volume":"17","author":"Aup\u00e9rin A","year":"2006","unstructured":"Aup\u00e9rinA Le P\u00e9chouxC PignonJP ; Meta-Analysis of Cisplatin\/carboplatin based Concomitant Chemotherapy in non-small cell Lung Cancer (MAC3-LC) Group. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients. Ann Oncol 2006;17 (3)473\u2013483","journal-title":"Ann Oncol"},{"issue":"35","key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1200\/JCO.2008.17.7840","article-title":"Hoosier Oncology Group; US Oncology. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology","volume":"26","author":"Hanna N","year":"2008","unstructured":"HannaN NeubauerM YiannoutsosC ; Hoosier Oncology Group; US Oncology. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 2008;26 (35)5755\u20135760","journal-title":"J Clin Oncol"},{"issue":"11","key":"e_1_3_2_32_2","first-page":"2744","article-title":"A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung","volume":"45","author":"Perez CA","year":"1980","unstructured":"PerezCA StanleyK RubinP A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 1980;45 (11)2744\u20132753","journal-title":"Preliminary report by the Radiation Therapy Oncology Group. Cancer"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71207-0"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1037::AID-CNCR5>3.0.CO;2-B"},{"issue":"9","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.1990.8.9.1543","article-title":"A randomized phase I\/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11","volume":"8","author":"Cox JD","year":"1990","unstructured":"CoxJD AzarniaN ByhardtRW ShinKH EmamiB PajakTF A randomized phase I\/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990;8 (9)1543\u20131555","journal-title":"J Clin Oncol"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.06.031"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-8140(99)00087-0"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(88)90347-1"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.034"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2014.11.002"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.4979"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.10.009"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.12.035"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2010.08.016"},{"issue":"3","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/JTO.0b013e3181653cf4","article-title":"Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer","volume":"3","author":"Stinchcombe TE","year":"2008","unstructured":"StinchcombeTE MorrisDE LeeCB Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer. J Thorac Oncol 2008;3 (3)250\u2013257","journal-title":"J Thorac Oncol"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181eba657"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4824"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.02.005"},{"issue":"25","key":"e_1_3_2_49_2","first-page":"5892","article-title":"TRIBUTE Investigator Group","volume":"23","author":"Herbst RS","year":"2005","unstructured":"HerbstRS PragerD HermannR ; TRIBUTE Investigator Group. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2005;23 (25)5892\u20135899","journal-title":"TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099314"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00143112"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.7353"},{"key":"e_1_3_2_53_2","first-page":"59","article-title":"START trial team","volume":"15","author":"Butts C","year":"2014","unstructured":"ButtsC SocinskiMA MitchellPL START trial team. Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. Lancet Oncol 2014;1559\u201368","journal-title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. Lancet Oncol"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.4032"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"e_1_3_2_58_2","article-title":"TNM Classification of Malignant Tumors, 7th ed","author":"Sobin L","year":"2009","unstructured":"SobinL GospodarowiczM WittekindC TNM Classification of Malignant Tumors, 7th ed. Wiley-Blackwell, Oxford 2009","journal-title":"Wiley-Blackwell, Oxford"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2004.04.021"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.05.039"},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","unstructured":"RiceTW RuschVW IshwaranH BlackstoneEH Worldwide Esophageal Cancer C. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer\/International Union Against Cancer Cancer Staging Manuals. Cancer. 116 3763\u20133773","DOI":"10.1002\/cncr.25146"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-9-45"},{"key":"e_1_3_2_63_2","unstructured":"NCCN Guidelines - Esophageal and Esophagogastric Cancers (excluding proximal 5 cm stomach). NCCN Clinical Practice Guideline in Oncology - Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/esophageal.pdf (Version 2.2013). Accessed November 16 2015."},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v7.i1.1"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608153350702"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.305"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70288-6"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9593"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00040-6"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(97)00569-5"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2004.06.033"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(03)00066-7"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.025080"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.5983"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70142-5"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2263-8"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-151"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.09.009"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.0506"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.05.029"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.17.1623"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.3471"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.5.1167"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<988::AID-CNCR7>3.0.CO;2-U"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt589"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70028-2"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.6918"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.4559"},{"key":"e_1_3_2_90_2","first-page":"311","article-title":"Is there a role for postoperative radiotherapy following open partial laryngectomy when prognostic factors on the pathological specimen are unfavourable?A survey of head and neck surgical\/radiation oncologists","volume":"33","author":"Russi EG","year":"2013","unstructured":"RussiEG SanguinetiG ChiesaF Is there a role for postoperative radiotherapy following open partial laryngectomy when prognostic factors on the pathological specimen are unfavourable?A survey of head and neck surgical\/radiation oncologists. Acta Otorhinolaryngol Ital 2013;33.311\u2013319","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-008-0901-8"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004050050228"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20181"},{"key":"e_1_3_2_94_2","first-page":"4155","article-title":"Exclusive radiotherapy for early-stage glottic cancer: a single-institution retrospective analysis with a focus on voice quality","volume":"35","author":"Potenza I","year":"2015","unstructured":"PotenzaI FrancoP MorettoF Exclusive radiotherapy for early-stage glottic cancer: a single-institution retrospective analysis with a focus on voice quality. Anticancer Res 2015;354155\u20134160","journal-title":"Anticancer Res"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2012.04.002"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1177\/0194599811400368"},{"key":"e_1_3_2_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.08.016"},{"key":"e_1_3_2_98_2","first-page":"1685","article-title":"Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer","volume":"324","year":"1991","unstructured":"Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study. N Engl J Med 1991;3241685\u20131690","journal-title":"The Department of Veterans Affairs Laryngeal Cancer Study. N Engl J Med"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds065"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.6097"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn460"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp007"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070956"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.3988"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.05.005"},{"key":"e_1_3_2_106_2","first-page":"6247","article-title":"Induction chemotherapy and sequential concomitant chemo-radiation in locally advanced head and neck cancers: how induction phase intensity and treatment breaks may impact on clinical outcomes","volume":"35","author":"Franco P","year":"2015","unstructured":"FrancoP PotenzaI SchenaM Induction chemotherapy and sequential concomitant chemo-radiation in locally advanced head and neck cancers: how induction phase intensity and treatment breaks may impact on clinical outcomes. Anticancer Res 2015;356247\u20136254","journal-title":"Anticancer Res"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-014-0264-9"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70039-6"}],"container-title":["Tumori Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/tj.5000525","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.5301\/tj.5000525","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.5301\/tj.5000525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:46:24Z","timestamp":1767663984000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.5301\/tj.5000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,7]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.5301\/tj.5000525"],"URL":"https:\/\/doi.org\/10.5301\/tj.5000525","relation":{},"ISSN":["0300-8916","2038-2529"],"issn-type":[{"type":"print","value":"0300-8916"},{"type":"electronic","value":"2038-2529"}],"subject":[],"published":{"date-parts":[[2016,2,7]]}}}